BCL2 and breast cancer: TQ treatment for 24 hours reduced the mRNA level expression of the anti-apoptotic B-cell lymphoma 2 (Bcl-2) gene in MDA-MB-231 and MCF-7 breast cancer cells, according to real-time qRT-PCR analysis.